However, we discovered that KMT2A expression was up- or downregulated in several cancer types and that KMT2A expression was linked with a favorable prognosis in certain cancer types (LGG, KIRC, and CHOL), while KMT2A expression was reduced in tumors. This evidence concerns the gene KMT2A and cancer.